Navigation Links
Alabama Hospitals Compare Infection Prevention Performance Statewide With New Benchmarking Tool
Date:4/29/2008

practices in infection prevention to be accurately identified and rapidly shared among a community of hospitals."

In this first-of-its-kind effort to encourage transparency and facilitate best practice sharing, hospitals using this new tool can voluntarily allow other hospitals to see the name of their institution in the benchmarking results. Those hospitals that choose to disclose their facility can see other hospitals who also granted permission to reveal their names in the results. Hospitals that choose to remain anonymous cannot view any other specific hospital names in the benchmarking results, even those who have chosen to be disclosed.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems, MedMined(TM) electronic infection surveillance service, VIASYS(R) respiratory care products and the CareFusion(TM) patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at
'/>"/>

SOURCE Cardinal Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
2. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
3. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
6. Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease
7. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
8. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
9. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
10. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
11. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...d not achieve statistical significance , , ...harmos Corporation (Nasdaq: PARS ) today announc... topical NanoEmulsion (NE) drug delivery technolog... , The multi-center, randomized, double-blin... and efficacy of the Company,s 3% Diclofenac Dieth...
(Date:11/19/2008)...Nov. 19 Biotech scientists increas...logy research to better understand the effects of ...s, reports Genetic Engineering & Biotechnolog... figuring out a new compound,s mechanism of action... technique, according to the November 15 issue of ...
(Date:11/19/2008)... Payment from Roche- , , MONTVALE, N.J., No...cals Corp. (Nasdaq: MEMY ) today announced that ...2 trial of R3487/MEM 3454, its lead alpha-7 nicoti...ciated with schizophrenia (CIAS). The Company has...ggering a $5.0 million payment from its partner Ro...
(Date:11/18/2008)...seals.org to learn more, make a donation or send ...v. 17 Millions will rec...esy of the American Lung Association. These decora...ing tradition dating back to 1907 when the Lung As..., , "Most Americans alive today have no vivi...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Annual NPSF Patient Safety Congress 18579 1Annual NPSF Patient Safety Congress 18579 2Annual NPSF Patient Safety Congress 18579 3Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea 5153 1Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea 5153 2NJIT applauds students for studies on brain injury glaucoma and more 3203 1NJIT applauds students for studies on brain injury glaucoma and more 3203 2WebMD Announces First Quarter Financial Results 18571 1WebMD Announces First Quarter Financial Results 18571 2WebMD Announces First Quarter Financial Results 18571 3WebMD Announces First Quarter Financial Results 18571 4WebMD Announces First Quarter Financial Results 18571 5WebMD Announces First Quarter Financial Results 18571 6WebMD Announces First Quarter Financial Results 18571 7WebMD Announces First Quarter Financial Results 18571 8WebMD Announces First Quarter Financial Results 18571 9WebMD Announces First Quarter Financial Results 18571 10WebMD Announces First Quarter Financial Results 18571 11WebMD Announces First Quarter Financial Results 18571 12WebMD Announces First Quarter Financial Results 18571 13WebMD Announces First Quarter Financial Results 18571 14WebMD Announces First Quarter Financial Results 18571 15WebMD Announces First Quarter Financial Results 18571 16WebMD Announces First Quarter Financial Results 18571 17WebMD Announces First Quarter Financial Results 18571 18WebMD Announces First Quarter Financial Results 18571 19WebMD Announces First Quarter Financial Results 18571 20
(Date:11/21/2008).../ -- The Generic,Pharmaceutical Association (GPhA...A President and CEO Kathleen Jaeger regarding the ...rging Health Care Competition and Consumer Issues....ng this roundtable demonstrates the,growing momen...safe and,affordable biogenerics sooner rather tha...
(Date:11/21/2008)...e University of Texas M. D. Anderson Cancer Cent...to eradicate breast cancer in Panama through the P...h of the Americas today at an event with Laura Bus... Fernandez de Torrijos, the First Lady of Panama. ...e are the U.S. Department of State and Susan G. Ko...
(Date:11/21/2008).../ -- U.S. News & World Report and the National...eChoice(R) HealthPlan of South Carolina in the top...ed in U.S. News & World Report,s issue this we...the nation,s best health plans based on clinical q... scores. NCQA and U.S. News & World Report ran...
(Date:11/21/2008)...ic damage that can lead to disease , , F...ications for treating attention-deficit hyperactiv...nked to an increased risk for developing cancer, a...rs at Duke University Medical Center and the Natio...that reported biomarkers associated with an increa...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2
...d that though they do not develop zits, the do hav...re able to differentiate the cells// in the sebace... The research examines how a sebaceous gland is fo...he August 11 issue of Cell, Elaine Fuchs, a Howard...
...more than 345 youngsters suffered from type1diabet...ases for the county, Dr Ian Gibson,// a former cha...tee, said in an interview that inbreeding might be...ontroversy. He said: "I would imagine it is linke...
...vitation into the world of drugs and the beginnin...to the vortex of drugs. Living up to peer expectat...g' and be the life of every party, drives many to...wns, drugs begin to call the shots and many lives ...
...Thursday edition of a local newspaper, Vietnam New...ndoms for the first time in Vietnam.// As a measu...nd distribution of condoms under a law on HIV/AIDS... 2007. Presently, condom sales and distribution ar...
Other Medicine News:Health News:'Blimp1' Gene Linked To Oily Skin 2Health News:Bitter Pill: Thrills That Kill 2Health News:Bitter Pill: Thrills That Kill 3
...ple, effective screening test which is used to ide...d sugar) levels which are often a warning sign of ...h requires a single drop of blood obtained from a ...n in clinical trials to be 94 to 99.95 percent acc...
The Lifestream Plus Cholesterol Monitor provides you with a comprehensive tool to help you monitor your cholesterol as part of your wellness program.
CardioChek™ PA Portable Whole Blood Test System
The Accustrip Strep A(ll) Test is a lateral flow, one-step immunoassay for the rapid, qualitative detection of Group A Streptococcal antigen from throat swabs. The test is intended for use as an aid
Medicine Products: